Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
256.43
+2.85 (1.12%)
Jun 27, 2025, 4:00 PM - Market closed
Penumbra Revenue
Penumbra had revenue of $324.14M in the quarter ending March 31, 2025, with 16.32% growth. This brings the company's revenue in the last twelve months to $1.24B, up 13.17% year-over-year. In the year 2024, Penumbra had annual revenue of $1.19B with 12.86% growth.
Revenue (ttm)
$1.24B
Revenue Growth
+13.17%
P/S Ratio
8.00
Revenue / Employee
$275,578
Employees
4,500
Market Cap
9.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.19B | 136.09M | 12.86% |
Dec 31, 2023 | 1.06B | 211.39M | 24.95% |
Dec 31, 2022 | 847.13M | 99.54M | 13.32% |
Dec 31, 2021 | 747.59M | 187.18M | 33.40% |
Dec 31, 2020 | 560.41M | 13.01M | 2.38% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PEN News
- 2 days ago - Penumbra: AI Meets Aspiration - Why The Stock Is A Structural Winner - Seeking Alpha
- 11 days ago - Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial - PRNewsWire
- 22 days ago - Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization - PRNewsWire
- 5 weeks ago - Penumbra, Inc. to Present at Upcoming Investor Conferences - PRNewsWire
- 2 months ago - Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference - PRNewsWire
- 2 months ago - Baron Health Care Fund Q1 2025 Top Net Purchases And Sales - Seeking Alpha
- 2 months ago - Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst - Benzinga
- 2 months ago - Penumbra, Inc. (PEN) Q1 2025 Earnings Call Transcript - Seeking Alpha